GeorgiaSB 722025-2026 Regular SessionSenateWALLET

"Hope for Georgia Patients Act"; enact

Sponsored By: John Albers (Republican), Matt Brass (Republican), Greg Dolezal (Republican), Drew Echols (Republican), Russ Goodman (Republican), Bo Hatchett (Republican), Chuck Hufstetler (Republican), Kay Kirkpatrick (Republican), Lanny Thomas (Republican), Randy Robertson (Republican), Brian Strickland (Republican), Carden Summers (Republican), Blake Tillery (Republican), Larry Walker (Republican), Rick Williams (Republican)

Became Law

HealthHealth and Human ServicesGeneral Bill

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

4 provisions identified: 2 benefits, 0 costs, 2 mixed.

Access to personalized experimental care

The law lets eligible patients ask for a personalized investigational treatment, and lets makers or facilities choose to provide it. A patient is eligible when a physician writes that the illness is life‑threatening or severely debilitating, all FDA‑approved options were considered, and a genomic‑based recommendation supports the treatment, plus written consent. These treatments are made for one patient and can include gene therapies, antisense drugs, or neoantigen vaccines; products from embryonic stem cells are excluded. The State of Georgia and its agents cannot block access, but medical advice that follows standards of care is allowed. Manufacturers and facilities are not required to provide treatment.

Who pays for personalized treatments

Health plans and government programs are not required to cover individualized investigational treatments. A maker or facility can provide the treatment for free, or require the patient to pay to manufacture it. Hospitals and facilities do not have to add new services to support these treatments. If death is caused by the treatment, the patient’s estate and heirs do not owe the remaining debt for that treatment’s charges; bills for nonexperimental care, including treatment of complications, still apply.

Legal shields for doctors and suppliers

The medical board cannot discipline a physician solely for recommending, prescribing, or giving an individualized investigational treatment. The state may not act against a provider’s Medicare certification just for making such a recommendation. Doctors cannot be sued under this article for refusing to recommend these treatments. Makers, facilities, and other caregivers are shielded from suits for harms if they followed this law in good faith and used reasonable care. Liability still applies if required written informed consent was not obtained.

Stronger consent for experimental care

Before treatment, the patient (or guardian) must sign a detailed consent form. It must list approved options, explain best and worst outcomes, and identify the proposed treatment. It must say your health plan is not required to pay and that hospice eligibility may be withdrawn. It must also state when you are responsible for expenses, except as limited elsewhere in the law.

Sponsors & Cosponsors

Sponsors

  • John Albers

    Republican • Senate

  • Matt Brass

    Republican • Senate

  • Greg Dolezal

    Republican • Senate

  • Drew Echols

    Republican • Senate

  • Russ Goodman

    Republican • Senate

  • Bo Hatchett

    Republican • Senate

  • Chuck Hufstetler

    Republican • Senate

  • Kay Kirkpatrick

    Republican • Senate

  • Lanny Thomas

    Republican • Senate

  • Randy Robertson

    Republican • Senate

  • Brian Strickland

    Republican • Senate

  • Carden Summers

    Republican • Senate

  • Blake Tillery

    Republican • Senate

  • Larry Walker

    Republican • Senate

  • Rick Williams

    Republican • Senate

Cosponsors

  • Lee Hawkins

    Republican • House

Roll Call Votes

All Roll Calls

Yes: 217 • No: 0

House vote 3/27/2025

PASSAGE

Yes: 161 • No: 0

Senate vote 2/24/2025

PASSAGE BY SUBSTITUTE

Yes: 56 • No: 0

Actions Timeline

  1. Effective Date

    7/1/2025
  2. Senate Date Signed by Governor

    5/12/2025Senate
  3. Act 122

    5/12/2025
  4. Senate Sent to Governor

    4/7/2025Senate
  5. House Third Readers

    3/27/2025House
  6. House Passed/Adopted

    3/27/2025House
  7. House Committee Favorably Reported

    3/20/2025House
  8. House Second Readers

    2/27/2025House
  9. House First Readers

    2/26/2025House
  10. Senate Third Read

    2/24/2025Senate
  11. Senate Passed/Adopted By Substitute

    2/24/2025Senate
  12. Senate Read Second Time

    2/12/2025Senate
  13. Senate Committee Favorably Reported By Substitute

    2/11/2025Senate
  14. Senate Read and Referred

    2/4/2025Senate
  15. Senate Hopper

    2/3/2025Senate

Bill Text

  • SB 72/AP* (v7)

Related Bills

Back to State Legislation